Physician profile
Anish B Nihalani
NPI 1447448212
$80,942.68
in general payments reported to CMS, 2019-2025
33 companies · $22K in 2025
The $22K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,356 · 2020: $702 · 2021: $539 · 2022: $1,271 · 2023: $6,373 · 2024: $46K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $51K · Travel and Lodging: $10K · Food and Beverage: $8,994 · Consulting Fee: $4,675 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $51,006.49 |
| Travel and Lodging | $10,391.26 |
| Food and Beverage | $8,993.64 |
| Consulting Fee | $4,675.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $57,879.13 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Tela Bio, INC. | $8,591.77 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| W. L. Gore & Associates, INC. | $4,845.08 | 2019-2025 | Seamguard, Gore Synecor Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Biotissue Holdings INC. | $1,952.10 | 2024 | |
| Becton, Dickinson and Company | $1,558.92 | 2024 | Phasix Mesh |
| Kerecis Limited | $987.81 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Senseonics, Incorporated | $886.00 | 2019-2020 | |
| Apollo Endosurgery US INC | $762.35 | 2022 | |
| Medtronic, INC. | $643.65 | 2022-2024 | Signia, Endoflip |
| Teleflex LLC | $412.34 | 2022-2025 | Titan Sgs Bailout Chuck, Titan Sgs Standard Gastric Stapler, Titan Sgs |
| Novo Nordisk INC | $328.36 | 2019-2025 | Wegovy |
| Ethicon US, LLC | $304.33 | 2019-2025 | Stratafix, Linx Reflux Management System |
| Ambu INC. | $266.36 | 2023-2025 | |
| Standard Bariatrics, INC. | $250.00 | 2019 | |
| Covidien LP | $240.56 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $139.99 | 2019-2024 | Perclot, Floseal |
| Currax Pharmaceuticals LLC | $132.27 | 2023-2025 | Contrave |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2023 | Farxiga |
| Conmed Corporation | $107.36 | 2019-2025 | Airseal |
| Lilly USA, LLC | $95.27 | 2023-2024 | Mounjaro, Zepbound, Jardiance |
| Medical Device Business Services, INC. | $70.53 | 2024 | Linx Reflux Management System |
| Daiichi Sankyo INC. | $57.20 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $55.56 | 2019-2023 | Nascobal |
| Phathom Pharmaceuticals, INC. | $54.20 | 2024-2025 | Voquezna |
| Smith+Nephew, INC. | $50.83 | 2019-2025 | Collagenase Santyl |
| Lexington Medical, INC. | $28.29 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Integra Lifesciences Corporation | $22.86 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $21.43 | 2024 | Phasix Mesh |
| Convatec INC. | $21.01 | 2024 | |
| Vivus LLC | $14.41 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.30 | 2019 | |
| Boston Scientific Corporation | $12.73 | 2019 | |
| Acell, INC. | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anish Nihalani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.